Skip to content
healthcare.dev

Dialyvite Supreme D

NDC 10542-009, Ascorbic Acid, Cholecalciferol, Alpha-Tocopherol, Thiamine, Riboflavin, Niacinamide, Pyridoxine, Folic Acid, Cobalamin, Biotin, Pantothenic Acid, Zinc, Selenium, tablet, coated, from Hillestad Pharmaceuticals USA.

Product NDC
10542-009
Status
Listed
Labeler
Hillestad Pharmaceuticals USA
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10542-009 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ASCORBIC ACID100 mg/1
  • CHOLECALCIFEROL2000 [iU]/1
  • .ALPHA.-TOCOPHEROL SUCCINATE, D-30 [iU]/1
  • THIAMINE MONONITRATE1.5 mg/1
  • RIBOFLAVIN1.7 mg/1
  • NIACINAMIDE20 mg/1
  • PYRIDOXINE HYDROCHLORIDE25 mg/1
  • FOLIC ACID3 mg/1
  • COBALAMIN1 mg/1
  • BIOTIN300 ug/1
  • CALCIUM PANTOTHENATE10 mg/1
  • ZINC CITRATE15 mg/1
  • SELENOCYSTEINE70 ug/1

Pharmacologic classes

Analogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]; Vitamin B 6 [Chemical/Ingredient]; Vitamin B6 Analog [EPC]; Vitamin C [EPC]; Vitamin D [CS]; Vitamin D [EPC]

Package NDCNDC-11Package
10542-009-02105420009027 TABLET, COATED in 1 BOTTLE, PLASTIC (10542-009-02)
10542-009-091054200090990 TABLET, COATED in 1 BOTTLE, PLASTIC (10542-009-09)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/46fc3acf-1e6d-4830-ae9a-abd9c1132fca
  • NADAC price for package 10542000909

    GET /v1/drugs/nadac/10542000909

Use it

Look up 10542-009 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10542-009 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10542-009. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.